CD28 co-stimulation is intact and contributes to prolonged ex vivo survival of hyporesponsive synovial fluid T cells in rheumatoid arthritis

European Journal of Immunology

Volumn 28, Issue 5, 1998, Pages 1554-1562

  Maurice, Madelon M ^a   Van Der Voort, Ellen A M ^a   Leow, Angela ^a   Levarht, Nivine ^a   Breedveld, Ferdinand C ^a   Verweij, Cornelis L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CD28; Glutathione; Rheumatoid arthritis; Survival; T lymphocyte

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CD28 ANTIGEN; CD3 ANTIGEN; GLUTATHIONE; INTERLEUKIN 15; INTERLEUKIN 2 RECEPTOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; OXIDATION REDUCTION STATE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; T LYMPHOCYTE;

ANTIGENS, CD28; ARTHRITIS, RHEUMATOID; CELL SURVIVAL; CELLS, CULTURED; HUMANS; IMMUNE TOLERANCE; INTRACELLULAR FLUID; LYMPHOCYTE ACTIVATION; OXIDATION-REDUCTION; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; T-LYMPHOCYTES;

EID: 0031894081     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199805)28:05<1554::AID-IMMU1554>3.0.CO;2-N     Document Type: Article

References (59)

1. Schwartz, R. H., A cell culture model for T lymphocyte clonal anergy. Science 1990. 248: 1349-1354.
2. Williams, M. E., Lichtman, A. H. and Abbas, A. K., Anti-CD3 antibody induces hyporesponsiveness to IL-2 in Th1 clones but not in Th2 clones. J. Immunol. 1990. 144: 1208-1214.
3. Williams, I. R. and Unanue, E. R., Costimulatory requirements of murine Th1 clones - the role of accessory cell-derived signals in response to anti-CD3 antibody. J. Immunol. 1990. 145: 85-93.
4. Lohoff, M., Schmitt, E., Reske-Kunz, A. B. and Röllinghoff, M., Different response of Th1 cells for stimulation with anti-CD3 antibodies. Eur. J. Immunol. 1990. 20: 653-658.
5. Jenkins, M. K. and Schwartz, R. H., Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 1987. 165: 302-319.
6. Gajewski, T. F., Schell, S. R., Nau, G. and Fitch, F. W., Regulation of T-cell activation: differences among T-cell subsets. Immunol. Rev. 1989. 111: 79-110.
7. Chen, C. and Nabavi, N., In vitro induction of T cell anergy by blocking B7 and early costimulatory molecule ETC/B7-2. Immunity 1994. 1: 147-154.
8. Schwartz, R. H., Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in IL-2 production and immunotherapy. Cell 1992. 71: 1065-1068.
9. Hansen, J. A., Martin, P. J. and Nowinski, R. C., Monoclonal antibodies identifying a novel T-cell antigen and la antigens of human lymphocytes. Immunogenetics 1980. 10: 247-260.
10. Gross, J. A., Callas, E. and Allison, J. P., Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 1992. 149: 380-388.
11. Linsley, P. S. and Ledbetter, J. A., The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 1993. 11: 191-212.
12. Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J. H., Lanier, L. L. and Somoza, C., B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993. 366: 76-79.
13. Freeman, G. J., Gribben, J. G., Boussiotis, V. A., Ng, J. W., Restivo, V. A., Lombard, L. A., Gray, G. S. and Nadler, L. M., Cloning of B7-2: A CTLA-4 counter-receptor that costimulated human T cell proliferation. Science 1993. 262: 909-911.
14. Boise, L. H., Noel, P. J. and Thompson, C. B., CD28 and apoptosis. Curr. Opin. Immunol. 1995. 7: 620-625.
15. Flynn, K. and Müllbacher, A., The generation of memory antigen-specific cytotoxic T cell responses by CD28/ CD80 interactions in the absence of antigen. Eur. J. Immunol. 1997. 27: 456-462.
16. Lu, L., Qian, S., Hershberger, P. A., Rudert, W. A., Lynch, D. H. and Thomson, A. W., Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J. Immunol. 1997. 158: 5676-5684.
17. Harris, E. D., Rheumatoid arthritis: pathophysiology and implications for therapy. N. Engl. J. Med. 1990. 322: 1277-1289.
18. Breedveld, F. C. and Verweij, C. L., T cells in rheumatoid arthritis. Br. J. Rheumatol. 1997. 36: 617-621.
19. Duke, O., Panayi, G. S., Janossy, G., Poulter, L. W. and Tidman, N. H., Analysis of T cell subsets in the peripheral blood and synovial fluid of patients with rheumatoid arthritis by means of monoclonal antibodies. Ann. Rheum. Dis. 1983. 42: 357-361.
20. Hemler, M. E., Glass, D., Coblyn, J. S. and Jacobson, J. G., Very late activation antigens on rheumatoid synovial T lymphocytes: association with stages of T cell activation. J. Clin. Invest. 1986. 78: 696-702.
21. Takahashi, H., Söderström, K., Nilsson, E., Kiessling, R. and Patarroyo, M., Integrins and other adhesion molecules on lymphocytes from synovial fluid and peripheral blood of rheumatoid arthritis patients. Eur. J. Immunol. 1992. 22: 2879-2885.
22. Laffon, A., Vicuna Garicia, R., Humbria, A., Postigo, A. A., Corbi, A. L., de Landazuri, M. O. and Sanchez Madrid, F., Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J. Clin. Invest. 1991. 88: 546-552.
23. Afeltra, A., Galeazzi, M., Ferri, G. M., Amoroso, A., De Pita, O., Porzio, F. and Bonomo, L., Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and chronic synovitis. Ann. Rheum. Dis. 1993. 52: 457-460.
24. Galeazzi, M., Afeltra, A., Porzio, F. and Bonomo, L., The activation markers on synovial T-cells of rheumatoid arthritis. Clin. Rheumatol. 1990. 9: 561.
25. Tak, P. P., Hintzen, R. Q., Teunissen, J. J. M., Smeets, T. J. M., Daha, M. R., van Lier, R. A. W., Kluin, P. M., Meinders, A. E., Swaak, A. J. G. and Breedveld, F. C., Expression of the activation antigen CD27 in rheumatoid arthritis. Clin. Immunol. Immunopathol. 1996. 80: 129-138.
26. 3H-thymidine incorporating cells in rheumatoid arthritis synovial membrane. Rheumatol. Int. 1986. 6: 269-271.
27. Haraoui, B., Wilder, R. L, Malone, D. G., Allen, J. B., Katona, I. M. and Wahl, S. M., Immune function in severe, active rheumatoid arthritis: a relationship between peripheral blood mononuclear cell proliferation to soluble antigens and mononuclear cell subset profiles. J. Immunol. 1984. 133: 697-701.
28. Kingsley, G. H., Pitzalis, C. and Panayi, G. S., Abnormal lymphocyte reactivity to self-major histocompatibility antigens in rheumatoid arthritis. J. Rheumatol. 1987. 14: 667-673.
29. Verwilghen, J., Vertessen, S., Stevens, E. A. M., Dequeker, J. and Ceuppens, J. L., Depressed T cell reactivity to recall antigens in rheumatoid arthirits. J. Clin. Immunol. 1990. 10: 90-98.
30. Pope, R. M., McChesney, L., Talal, N. and Fischbach, M., Characterization of the defective autologous mixed lymphocyte response in rheumatoid arthritis patients. Arthritis Rheum. 1984. 27: 1234-1244.
31. Keystone, E. C., Poplonski, L., Miller, R. G., Gorczynski, R., Gladman, D. and Snow, K., Reactivity of T cells from patients with rheumatoid arthritis to anti-CD3 antibody. Clin. Immunol. Immunopathol. 1988. 48: 325-337.
32. Brennan, F. M., Maini, R. N. and Feldmann, M., Cytokine expression in chronic inflammatory disease. Br. Med. Bull. 1995. 51: 368-384.
33. Chen, E., Keystone, E. C. and Fish, E. N., Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum. 1993. 36: 901-910.
34. Firestein, G. S., Xu, W. D., Townsend, K., Broide, D., Alvaro-Gracia, J., Glasebrook, A. and Zvaifler, N. J., Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (IL-2 and IL-3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J. Exp. Med. 1988. 168 1573-1586.
35. Firestein, G. S. and Zvaifler, N. J., Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that gamma-interferon is not the primary macrophage activating factor. Arthritis Rheum. 1987. 30: 864-871.
36. Firestein, G. S. and Zvaifler, N. J., How important are T cells in chronic rheumatoid arthritis? Arthritis Rheum. 1990. 33: 768-773.
37. Mirza, N. M., Relias, V., Yunis, E. J., Pachas, W. N. and Dasgupta, J. D., Defective signal transduction via T-cell receptor-CD3 structure in T cells from rheumatoid arthritis patients. Hum. Immunol. 1993. 36: 91-98.
38. Allen, M. E., Young, S. P., Michell, R. H. and Bacon, P. A., Altered T lymphocyte signaling in rheumatoid arthritis. Eur. J. Immunol. 1995. 25: 1547-1554.
39. Maurice, M. M., Lankester, A. C., Bezemer, A. C., Geertsma, M. F., Tak, P. P., Breedveld, F. C., van Lier, R. A. W. and Verweij, C. L., Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis. J. Immunol. 1997. 159: 2973-2978.
40. Maurice, M. M., Nakamura, H., van der Voort, E. A. M., van Vliet, A. I., Staal, F. J. T., Tak, P. P., Breedveld, F. C. and Verweij, C. L., Evidence for a role of an altered redox state in hyporesponsiveness of synovial T cells in rheumatoid arthritis. J. Immunol. 1997. 158: 1458-1465.
41. Van den Broek, M., Boeije, L., Swaak, T., Smeenk, R. and Aarden, L., Functional analysis of synovial fluid and peripheral blood T cells from patients with rheumatoid arthritis. Rheumatol. Int. 1995. 15: 137-143.
42. Salmon, M., Scheel-Toellner, D., Huissoon, A. P., Pilling, D., Shamsadeen, N., Hyde, H., Dupuy D'Angeac, A., Bacon, P. A., Emery, P. and Akbar, A. N., Inhibition of T cell apoptosis in the rheumatoid synovium. J. Clin. Invest. 1997. 99: 439-446.
43. Firestein, G. S., Yeo, M. and Zvaifler, N. J., Apoptosis in rheumatoid arthritis synovium. J. Clin. Invest. 1995. 96: 1631-1638.
44. McInnes, I. B., Al-Mughales, J., Field, M., Leung, B. P., Huang, F. P., Dixon, R., Sturrock, R. D., Wilkinson, P. C. and Liew, F. Y, The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nature Med. 1996. 2: 175-182.
45. Thurkow, E. W., van der Heijden, I. M., Breedveld, F. C., Smeets, T. J. M., Daha, M. R., Kluin, P. M., Meinders, A. E. and Tak, P. P., Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. J. Pathol. 1997. 181: 444-450.
46. Meyaard, L., Kuiper, H., Otto, S. A., Wolthers, K. C., van Lier, R. A. W. and Miedema, F., Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells from human immunodeficiency virus-infected individuals. Eur. J. Immunol. 1995. 25: 232-237.
47. + T cells cannot be overcome by CD28 stimulation. Eur. J. Immunol. 1994. 24: 1956-1960.
48. Liu, M. R, Kohsaka, H., Sakurai, H., Azuma, M., Okumura, K., Saito, I. and Miyasaka, N., The presence of costimulatory molecules CD86 and CD28 in rheumatoid arthritis synovium. Arthritis Rheum. 1996. 39: 110-114.
49. Ranheim, E. A. and Kipps, T. J., Elevated expression of CD80 (B7/BB1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritis. Arthritis Rheum. 1997. 37: 1637-1646.
50. Robertson, S. E., Young, S. P., Viner, N. J. and Bacon, P. A., Enhanced costimulatory ability of synovial accessory cells in rheumatoid arthritis. Br. J. Rheum. 1997. 36: 413-419.
51. Grabstein, K. H., Eisenman, J., Shanebeck, K et al., Clonin of a T cell growth factor that interacts with the β-chain of the interleukin-2-receptor. Science 1994. 264: 965-967.
52. Burton, J. D., Bamford, R. N., Peters, C. et al., A lymphokine, provisionally designed interleukin T and produced by a human adult T cell leukemia line, stimulates T cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 1994. 91: 4935-4939.
53. Giri, J. G., Ahdieh, M., Eisenmann, J. et al., Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 1994. 13: 2822-2830.
54. Giri, J. G., Kumaki, S., Ahdieh, M. et al., Identification and cloning of a novel IL-15 binding protein that is structurally related to the a chain of the IL-2 receptor. EMBO J. 1995. 14: 3654-3663.
55. McInnes, I. B., Leung, B. P., Sturrock, R. D., Field, M. and Liew, F. Y., Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nature Med. 1997. 3: 189-195.
56. L. Immunity 1995. 3: 87-98.
57. Harlan, D. M., Abe, R., Lee, K. P. and June, C. H., Potential roles of the B7 and CD28 receptor families in autoimmunity and immune evasion. Clin. Immunol. Immunopathol. 1995. 75: 99-111.
58. Arnett, F. C., Edworthy, S. M., Bloch, D. A. et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1987. 31: 315-324.
59. Gavrieli, Y., Sherman, Y. and Ben-Sasson, S. A., Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 1992. 119: 493-501.